Wofford, Marion R., M.D.

Primary Practice Location:
University Hospital
2500 N. State St.
Jackson, MS 39216

Appointments: (888) 815-2005

Areas of Practice: Hypertension, Internal Medicine

Education

Board Certification:	Internal Medicine
Medical Education:	University of Mississippi School of Medicine
Residency Program:	University of Mississippi Medical Center

Current Positions

Medical Director of Adult Hospital , School of	07/2013 - Present
Professor , School of Medicine, Department of Medicine	07/2007 - Present
The University of Mississippi Medical Center Jackson, Mississippi 39216

Education

Harvard School of Public Health, MPH, Master of Public Health	1998
University of Mississippi Medical Center, Internal Medicine	1997
University of Mississippi Medical Center, Internal Medicine	1996
University of Mississippi School of Medicine, MD, Medicine	1993
Millsaps College, BS, Biology	1978

Specialty Certification Licensure

Re-certification, The American Board of Internal Medicine, The American Board of Internal Medicine	2007 - 2017
Licensure, Mississippi State Board of Medical Licensure	07/1994 - 06/2011
Certification, The American Board of Internal Medicine, The American Board of Internal Medicine	1997 - 2007

Academic Appointments or Other Previous Appointments

Chief of Staff, UMMC, School of	07/2012 - 06/2013
Associate Professor, University of Mississippi Medical Center, School of Medicine, Department of Medicine	2004 - 2007
Associate Professor, University of Mississippi Medical Center, School of Graduate, Department of Medicine	2003 - 2004
Associate Professor, Unversity of Mississippi Medical Center, School of Medicine, Department of Medicine	2003 - 2004
Assistant Professor, University of Mississippi Medical Center, School of Medicine, Department of Medicine	12/2002 - 2003
Assistant Professor, University of Mississippi Medical Center, School of Medicine, Department of Medicine	1997 - 2002

Honors, Awards, and Recognition

Best Doctors in America	2011
Gold Level Award for Excellence in Research, University of Mississippi Medical Center	2011
Herbert G Langford Professor of Medicine	2010
Specialist in Clinical Hypertension:American Society of Hypertension	2009
Silver Level Award for Excellence in Research, Univeristy of Mississippi Medical Center	2006
Who's Who in Medicine and Healthcare	2004
Alliance for Academic Internal Internal Medicine-Merck Executive Leadership Program	2004
Fellow of American Heart Association Council for High Blood Pressure Research	2003
Best Doctors in America	2001
Fellow of the American College of Physicians	2001
Best Doctors in America	1998
American Society of Hypertension Bristol-Myers Squibb Recognition Award	1996
Hellums Award- House Officer of the Year, Department of Medicine University of Mississippi Medical Center	1995
Quality Care Award, Department of Veterans Affairs	1995
Omicron Delta Kappa Honorary Society, Millsaps College	1975
Sigma Lambda Leadership Honorary, Millsaps College	1975
Vice President fo Student Body, Millsaps College	1975
Who's Who Among Students in American Univeristies and Colleges, Millsaps College	1975

President of third and fourth year medical school classes, University of Mississippi Medical Center

Professional Membership and Service

The American Society of Hypertension, Inc., Member-at-Large, Gulf Coast Regional Chapter	2010 - Present
American Society of Hypertension, Committee Member, specialists exam committee meeting	2008
American Heart Association, Committee Member, Scientific Grant Review committee	2008 - Present
American Society of Hypertension, Committee Member, Nominating Committee Meeting	2008
Chronic Disease Program, Medical Consultant	2008 - Present
The American Society of Hypertension, Inc., Member, Hypertension Specialist Exam Committee	2008 - Present
USMLE Step 3 Scripting Committee, Member	2008 - Present
The American Society of Hypertension, Inc., Member, The American Society of Hypertension, Inc. Hypertension Specialist Exam Committee 2008 -2013	2008 - 2013
American Heart Association, Chairperson, Go Red for Women Luncheon	2008 - 2009
American Society of Hypertension, Committee Member, National Leadership forum	2008
American Society of Hypertension, Committee Member, Program Committee meeting	2007
American Society of Hypertension, Committee Member, Regional Chapters Presidents meeting	2007
The American Society of Hypertension Gulf Coast Regional Chapter, Officer, President/Elect/Past	2006 - Present
Mississippi Blue Cross/Blue Shield Metabolic Syndrome Committee, Medical Consultant	2006 - 2009
The American Society of Hypertension, Inc., Officer, President/Elect/Past, Gulf Coast Regional Chapter	2006 - 2009
The Journal of Clinical Hypertension, Reviewer, Journal Article	2005 - Present
The American Society of Hypertension, Inc., Officer, Vice President, Gulf Coast Regional Chapter	2005 - 2006
National Board of Medical Examiners, USMLE, Member, Step 3 Computer-Based Case Simulation	2004 - 2008
American Heart Association, Member, Council on High Blood Pressure Research	2003 - Present
The Wilson Research Foundation, Board of Governors	2003 - Present
The American Society of Hypertension, Inc., Committee Member	2003 - 2009
The American Society of Hypertension, Inc., Member, Membership Committee, 2003 – 2009	2003 - 2009
The American Society of Hypertension, Committee Member, Gulf Coast Regional Chapter	2002 - Present
USMLE, Committee Member, CCS- testing committee	2002 - Present
Hypertension Journal of the American Heart Association, Editorial Review Board Member	2002 - 2007
18th Scientific Meeting of the International Society of Hypertension, Abstract Reviewer	2000 - Present
Southern Medical Journal, Reviewer, Journal Article	2000 - 2005
American Society of Hypertension, Member, Gulf Central Regional Chapter	2000 - Present
Cardiovascular Disease Ad Hoc Committee, Committee Vice Chair, Mississippi Department of Health- Mississippi Chronic Illness Coalition	2000 - Present
Consortium for Cardiovascular Disease Prevention Strategies in Mississippi, Sterring Comittee Member	2000 - Present
Journal of Medical Sciences, Editorial Review Board Member	1999 - Present
The Journal of Medical Sciences, Editorial Review Board Member	1999 - 2005
Women's Health Inititative of Mississippi, Board of Directors of a Company	1999 - Present
American Society of Hypertension, Member, ASH Specialist in Clinical Hypertension	1999 - 2009
Central Medical Society of Mississippi, Member, State Delegate	1999
Mississippi State Department of Health, Consultant, Chronic Disease Program	1998
Southern Society for Clinical Investigation, Member	1997 - Present
American Medical Association, Member	1997 - 2010
International Society on Hypertension in Blacks, Member	1997 - 2002
The American Society of Hypertension, Member	1996 - Present
Wilderness Ventures, Inc., Program Coordinator, Summer Course Director	1982 - 1991
Jackson Preparatory High School, Instructor, Biology	1980 - 1988

American College of Physicians, Member
American Federation for Medical Research, Member
American Society of Internal Medicine, Member
Consortium for Southeastern Hypertension Control, Member
Mississippi State Medical Society, Member
Society of General Internal Medicine, Member
Southern Medical Association, Member

Committee Service

ASH Nominating Committee, Member	2013 - 2014
ASH Specialitst Program Examination Committee, Member	2013 - 2014
Student Employee Task Force, Member	2012 - Present
Epic Steering Committee, Member	2011 - Present
Department of Medicine Clinical Council, Member	2011 - 2012
Department of Medicine Promotions and Tenure Committee, Member	2011 - 2012
Medical Center - Research Advisory Committee, Member	2007 - Present
Medical Center - Institutional Quality Board, Member	2007 - 2008
Medical Center - Conflict Of Interest, Member	2006 - Present
The University Hospitals and Clinics - Accreditation and Bylaws, Chair	2000 - 2001
School of Medicine- Research Development Committee, Member	2000 - Present
Medical Center- Appeals and Grievance Committee, Member	2000 - 2000
The University Hospitals and Clinics - Accreditation and Bylaws, Member	1999 - 2000
Medical Center - Compliance, Member	1999 - Present
Medical Center - Research Advisory Committee, Member	1999 - 2004
School Of Graduate Studies - Graduate Council, Member	1998 - Present
School Of Medicine - Residency Review Subcommittee, Member	1998 - 2000
Medical Center- House Officer Selection Committee, Member	1997 - 2002
School of Medicine- Medical Education Committee, Member	1996 - 1997
Quality and Assurance Committee, Member	1995 - 1995
School of Medicine- Self Study Committee, Member	1995 - 1995
The University Hospitals and Clinics - Pharmacy and Therapeutics, Member	1995 - 1995

Other Service

Chief of Medical Staff	2011 - Present
University Mississippi Medical Center Medical Staff, Vice Chief	2009 - 2011
Institutional Quality Board, Member	2007 - 2008
Research Strategic Task Force, Member	2003 - 2006
Department of Medicine Research Council, Member	2001 - Present
Heath Insurance Portability and Accountability Act, Member	2000 - 2007
Clinical Research Program, Director	1999 - Present
Education Council, Member	1998 - 2002
Division of Hypertension, Education Coordinator	1998 - 2000
Introduction to Clinical Medicine, Preceptor	1998 - 2000
Residency Program Department of Medicine, Associate Program Director	1998 - 2000
Ambulatory Medicine, Attending Member	1997 - Present
Center for Excellence in Cardiovascular-Renal Research, Member	1997 - Present
General Medicine Teaching Service, Attending Member	1997 - Present
Microbiology Laboratory, Technician	1989 - 1989

Sponsored Program Funding

Intramural, Systolic Blood Pressure Intervention Trial. Sprint, NIH Subcontract with UAB, Birmingham	09/2010 - 09/2018
Extramural, The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients with Type 2 Diabetes Mellitus. Protocol H9X-MC-GBDN, Eli Lilly and Company	07/2010 - 06/2011
Extramural, A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects with Unstable Angina/Non ST Elevation Myocardial Infarction Who are Medically Managed (Trilogy), Eli Lilly & Company	08/2008 - 04/2011
Extramural, A Phase III, Double-Blind, Randomized Placebo-Controlled Study to Evaluate the Effects of RO4607381 on Cardiovascular Risk in Stable CHD Patients with a Documented Recent Acute Coronary Syndrome, Hoffman-LaRoche, Inc.	01/2008 - 07/2012
Intramural, Investigation of Reduction of Blood Pressure and Metabolic Rate in Obese Hypertensive Patients Using Eplerenone:Implications for Treatment of Hypertension and Heart Failure	11/2006 - 11/2008
Extramural, A 10-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, forced-Titration Study Using 24-Hour ABPM to Evaluate the Efficacy of a Valsartan/Hydrochlorothiazide (HCTZ) Treatment Regimen Versus Conventional Treatment Regimen with Amlodipine and Hydrochlorothiazide (HCTZ) in Patients with State 2 Hypertension, Novartis Pharmaceuticals	11/2006 - 07/2008
Extramural, A Multicenter, Randomized, Double-Blind, Active Controlled Study to Compare the Effect of 24 Weeks Treatment with Vildagliptin 100 mg qd or Metformin 1500 mg Daily in Elderly Drug Naive Patients with Type 2 Diabetes (LAF237A), Novartis Pharmaceuticals	09/2006 - 08/2008
Extramural, A 54-Week, Open Label, Multicenter Study to Assess the Long Term Safety and Combination of Aliskiren 300 mg/Valsartan 320 mg in Patients with Essential Hypertension, Novartis Pharmaceuticals	07/2006 - 08/2008
Extramural, Liraglutide Effect and Action in Diabetes: Effect on Glycemic Control of Laraglutide versus Glimepiride in Type 2 Diabetes. A 52 Week Double-Blind, Multicenter, Randomized, Parallel Study to Investigate Safety and Efficacy (LEAD), Abbott/Covance	04/2006 - 04/2009
Extramural, A Long-Term, Open-Label, Safety Extension Study of the Combination of Fenofibric Acid and Statin Therapy for Subjects with Mixed Dyslipidemia (M05-758), Novo Nordisk	01/2006 - 12/2007
Extramural, A Multicenter, Randomized, Double-Blind, Prospective Study Comparing the Safety and Efficacy of Fenofibric Acid and Atorvastatin Calcium Combination Therapy to Fenofibric Acid and Atorvastatin Calcium Monotherapy in Subjects with Mixed Dyslipidemia, Novo Nordisk	01/2006 - 12/2007
Extramural, A Double-Blind, Randomized, Placebo and Active Controlled Forced Titration Study Evaluating the Effects of Nebivolol on Blood Pressure and Heart Rate in African American Patients with Hypertension, Mylan/Bertek Pharmaceuticals	04/2005 - 03/2007
Extramural, Hypertension Education and Treatment (HEAT) Partnership, NIH/HNLBI	09/2004 - 08/2009
Extramural, Clinical Trial of Dietary Protein on Blood Pressure, NHLBI	07/2004 - 06/2008
Extramural, An 8-Week Double-Blind, Multicenter, Randomized, Multifactorial, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aliskiren Administered Alone and in Combination with Hydrochlorothiazide in Patients with Essential Hypertension (“Study 100A”), Novartis Pharmaceuticals	07/2004 - 02/2006
Extramural, Clinical Utility of Caduet in Simultaneously Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population, Pfizer Pharmaceuticals	05/2004 - 12/2005
Extramural, A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Active-Controlled Trial to Compare the Effects of Lotrel (amlodipine/benazepril) to Benazepril and Hydrochlorothiazide Combined on the Reduction of Cardiovascular Morbidity and Mortality in Patients with High Risk Hypertension, Novartis	10/2003 - 06/2009
Extramural, A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Active-Controlled Trial to Compare the Effects of Lotrel to Benaepril and Hydrochlorothiazide Combined on the Reduction of Cardiovascular Morbidity and Mortality in Patients with High Risk Hypertension, Novartis Pharmaceuticals	10/2003 - 06/2009
Extramural, A Multi-Center, Randomized, Double-Blind, Double-Dummy Study Evaluating the Safety and Efficacy of the Addition of Amlodipine to Quinapril or Losartan in the Treatment of Diabetic Hypertensive Subjects, Pfizer Pharmaceuticals	04/2003 - 03/2004
Extramural, A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c) of AC2993 Given Two Times a Day in Subjects with Type 2 Diabetes Mellitus Treated with Sulfonylurea Alone, Amylin Pharmaceuticals	04/2003 - 12/2003
Extramural, A Double-Blind, Randomized, Vehicle-Controlled Study Comparing the Safety and Efficacy of Benzydamine Hydrochloride 0.15% Oral Rinse Including a Separate Open-Label Standard of Care Arm in Subjects with Radiation-Induced Oral Mucositis, McNeil Consumer & Speciality Pharmaceuticals	03/2003 - 03/2004
Extramural, A Randomized, Double-Blind, Multicenter, Multifactorial, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients, Novartis Pharmaceuticals	10/2002 - 10/2004
Extramural, Dose Finding, Efficacy, and Safety of AZ 242 in Subjects with Type 2 Diabetes, Protocol 270, AstraZeneca	08/2002 - 08/2003
Extramural, Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cevimeline in the Treatment of Xerostomia Secondary to Radiation Therapy for Cancer in the Head and Neck Region, Daiichi Pharmaceutical Corporation	08/2002 - 08/2003
Extramural, Clinical Trial of Dietary Protein on Blood Pressure, National Institution of Health (NIH)	07/2002 - 06/2003
Extramural, A 6-week, Randomized, Open-Label, Comparative Study to Evaluate the Efficacy and Safety of Rosuvastatin and Atorvastatin in the Treatment of Hypercholesterolemia in African American Subjects, AstraZeneca	06/2002 - 12/2003
Extramural, A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c) of AC2993 Given Two Times a Day in Subjects with Type 2 Diabetes Mellitus Treated with Metformin and a Sulfonylurea, Amylin Pharmaceuticals	05/2002 - 02/2004
Extramural, A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c), of AC2993 Given Two Times a Day in Subjects with Type 2 Diabetes Mellitus Treated with Metformin Alone, Amylin Pharmaceuticals	04/2002 - 12/2003
Extramural, DioVan Antihypertensive Long-Term Use Evaluation: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Active-Controlled Trial in Patients with Essential Hypertension to Compare the Effect of Valsartan 80 and 160 mg, with or without the addition of hydrochlorothiazide, once daily to that of amlodipine 5 and 10 mg once daily, with or without the addition of hydrochlorothiazide, on cardiovascular morbidity and mortality (VALUE Study), Novartis Pharmaceuticals	03/2002 - 03/2005
Extramural, A Multicenter, Double-Blind, Randomized Study to Evaluate the Effects of Valsartan and the Combination of Valsartan and Simvastatin on Blood Pressure (Ambulatory and Standard Cuff) and on Selected Biochemical Markets of Endothelial Function, Safety and Tolerability (VAS Study), Novartis Pharmaceuticals	03/2002 - 03/2003
Extramural, A Randomized, Multicenter, Double-Blind, Parallel Group Study to Determine the Efficacy and Safety of Lotrel versus Enalapril in the Treatment of Hypertension in an African-American Population with Type 2 Diabetes (Lotrel Study), Novartis Pharmaceuticals	02/2002 - 10/2003
Extramural, A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Long Term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects with Impaired Glucose Tolerance (The Navigator Study), Novartis Pharmaceuticals	12/2001 - 09/2010
Extramural, A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Long Term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects with Impaired Glucose Tolerance (IGT)(The Navigator Study), Novartis Pharmaceuticals	11/2001 - 09/2009
Extramural, Pravastatin or Atorvastatin Evaluation and Infection Therapy (Prove It), Bristol-Myers Squibb	09/2001 - 09/2004
Extramural, Antihypertensive Efficacy of Adding Candesartan Cilexetil to Lisinopril in Comparison to Up-titration of Lisinopril (AMAZE), Astra Zeneca	09/2001 - 09/2002
Extramural, Genetics of Microangiographic Brain Injury; Sub-study on Ambulatory Blood Pressure Study. Sub-contractor under Mayo Clinic of Rochester, National Institutes of Health/National Institute of Neurological Disorders and Stroke	05/2001 - 05/2006
Extramural, Multicenter, Randomized, Double-Blind, Placebo-Controlled and Open-Label Evaluation of the Safety and Efficacy of Dual therapy with Atorvastatin Plus Amlodipine When Compared to Either Therapy Alone in the Treatment of Patients with Simultaneous Hyperlipidemia and Hypertension (The AVALON Study), Pfizer Pharmaceuticals	05/2001 - 07/2003
Extramural, Omapatrilat in Persons with Enhanced Risk of Atherosclerotic Events (OPERA) (CV137-056), Bristol-Myers Squibb	12/2000 - 12/2005
Extramural, A Multicenter, Randomized, Double-Blind, Active Control Trial to Evaluate the Safety and Efficacy of Metformin/Glyburide Tablets as First Line Therapy in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control with Diet and Exercise (CV138-054), Bristol-Myers Squibb	07/2000 - 03/2001
Extramural, A Multicenter, Randomized, Double-Blind, Parallel Group Trial Comparing the Safety and Efficacy of Metformin/Glyburide to Pioglitazone as First Line Therapy in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control with Diet and Exercise (CV138-056), Bristol-Myers Squibb	06/2000 - 03/2001
Extramural, Clinical Protocol for a Double-Blind, Randomized, Placebo and Active-Controlled Comparison Study of the Antihypertensive Effect and Safety of Eplerenone Versus Placebo and Versus Losartan in Black and White Hypertensive Patients (020), G. D. Searle	11/1999 - 12/2000
Extramural, A Double-Blind, Randomized Study Comparing the Effects of a Modified-Release Formulation of Pravastatin with Placebo and with Atorvastatin in Patients with Hypercholesterolemia, Bristol-Myers Squibb	09/1999 - 08/2001
Extramural, Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM), AstraZeneca	08/1999 - 07/2003
Extramural, Evaluation of the Antihypertensive Efficacy of Candesartan Cilexetil in Comparison to Losartan: A Multicenter, Double-Blind, Randomized, Parallel-Group, Forced-Titration Study (CLAIM), AstraZeneca	08/1999 - 02/2000
Extramural, Clinical Protocol for a Double-Blind, Controlled, Randomized Comparison of Eplerenone and Losartan in Patients with Low Renin Hypertension (019), G. D. Searle	07/1999 - 07/2000
Extramural, Clinical Protocol for a Double-Blind, Controlled, Randomized Comparison Study of the Antihypertensive Effect of Eplerenone and Spironolactone in Patients with Hypertension Secondary to Primary Aldosteronism (018), G. D. Searle	07/1999 - 07/2000
Extramural, A Randomized, Double-Blind, Amlodipine-and Losartan-Controlled Study of Omapatrilat in Subjects with Mild to Moderate Hypertension, Bristol-Myers Squibb	03/1999 - 01/2000
Extramural, Jackson Heart Study (Examination Center), NIH/NHLBI	01/1999 - 12/2005
Extramural, Controlled Onset Verapamil Investigation of Cardiovascular Endpoints (CONVINCE Study), G. D. Searle	07/1998 - 09/2003
Extramural, A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Long-Term Trial of Preventing Hypertension Using Candesartan Cilexetil 16mg in Patients with High Normal Blood Pressure (TROPHY), AstraZeneca	03/1998 - 03/2004
Extramural, ABC Study of Hypertension: Efficacy of Candesartan Cilexetil in Hypertensive Black Patients, Astra-Merck	01/1998 - 12/1999
Extramural, Jackson Heart Study (Feasibility Phase), NIH/NHLBI	10/1997 - 09/1999
Extramural, Mississippi Hypertension Disease Management Network, Merck & Co., Inc	01/1997 - 12/1998
Intramural, Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), NIH/NHLBI- University of Texas	09/1994 - 08/2001

Publications

Article
Jiang He, Marion R. Wofford, Kristi Reynolds, Jing Chen, Chung-Shiuan Chen, Leann Meyers, Deborah L. Minor, Patricia J. Elmer, Daniel W. Jones and Paul K. Whelton Effect of Dietary Protein Supplementation on Blood Pressure: A Randomized Control Trial Circulation A Journal of the American Heart Association	2011
Journal Article
Riche DM, Riche KD, Blackshear CT, McEwen CL, Sherman JJ, Wofford MR, Griswold ME. Pterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial. Evid Based Complement Alternat Med. 2014;2014:459165. doi: 10.1155/2014/459165. Epub 2014 Jun 25.	2014
Riche DM,Wilson L,Jackson RT,Wofford MR,Adams C. Effect on institutional revenue of clinical pharmacy services in an ambulatory care clinic. Am J Health Syst Pharm.2013 Mar 15;70(6):482,484.	2013
Riche DM, McEwen CL,Riche KD,Sherman JJ,Wofford MR,Deschamp D,Griswold M. Analysis of safety from a human clinical trial with pterostilbene. J Toxicol. 2013;2013.	2013
Malinowski SS, Byrd JS, Bell AM, Wofford, MR, Riche DM Pharmacologic Therapy For Nonalcoholic Fatty Liver Disease in Adults. Pharmacotherapy.2013 Feb;33(2):223-42. dio: 10.1002/phar.1190.Epub 2013 Jan 28	2013
Rebholz CM, Reynolds K, Wofford MR, Chen J, Kelly TN, Mei H, Whelton PK, He J. Effect of Soybean Protein on Novel Cardiovascular Disease Risk Factors: A randomized controlled trial. Eur J Clin Nutr. 2013 Jan; 67 (1):58-63. doi: 10.1038/ejcn.2012.186. Epub 2012 Nov 28	2012
Call RJ, Wofford MR, Riche DM Top 10 Facts You Should Know About Diabetes J Miss State med Assoc. 2012 Aug:53(8):275-7.	2012
Roberta Lima & Marion Wofford & Jane F. Reckelhoff Hypertension in Postmenopausal Women Curr Hypertens Rep 14(3): 254-60, June 2012.	2012
Lima R, Wofford, MR, Reckelhoff JF Lima R, Wofford, MR, Reckelhoff JF. Hypertension in Postmenopausal Women. Current Hypertens Rep. 2012 Mar 17. Current Hypertens Rep. 2012 Mar 17.	2012
Wyatt SB, Akylbekova EL, Wofford MR, Coady SA, Walker ER, Andrew ME, Keahey Wj, Taylor HA, Jones DW Prevalence, Awareness, Treatment, and Control of Hypertension in the Jackson Heart Study Hypertension, 2008;Mar;51(3):650-6	2008
Long RC, wofford MR, Harkins KG, Minor DS Hepatocellular Necrosis Associated With Labetalol J Clin Hypertens, 2007;Apr;9(4):287-90	2007
Currier M, King DS, Wofford MR, Daniel BJ, Deshazo R A Katrina experience: lessons learned Am J Med. 2006 Nov; 119 (11):986-92	2006
Wofford MR, King DS, Harrell TK Drug-Induced Metabolic Syndrome J Clin Hypertens 2006; 8:114-119	2006
Mellen PB, Bleyer AJ, Erlinger RP, Evans GW, Nieto FJ, Wagenknecty LE, Wofford MR, Herrington DM Serum Uric Acid Predicts Incident Hypertension in a Biethnic Cohort The Atherosclerosis Risk in Communities Study. Hypertension. 2006 Dec;48(6):1037-42. Epub 2006 Oct. 23	2006
Brock CC, King DS, Wofford MR, Harrell TK Exercise, Insulin Resistance, and Hypertension: A Complex Relationship Metabolic Syndrome and Related Disorders. Mar 2005, Vol. 3, No. 1: 60-65	2005
Egan BM, Papademetriou V, Wofford M, Calhoun D, Fernandes J, Riehle JE, Nesbitt S, Michelson E, Julius S, for the Trophy Sub-study Investigated Team Metabolic Syndrome and insulin resistance in the Trophy sub-study: contrasting views in patients with high-normal blood pressure Am J Hypertens 2005; 18:3-12	2005
Wofford,MR, King DS Relationship Between Antihypertensive Drugs and Metabolic Syndrome Metabolic Syndrome and Related Disorders. 2004;2(4):308-314	2004
Wilburn AM, King DS, Gisson J, Rockhold RW, Wofford MR Natural Treatment of Hypertension J Clin Hypertens. 2004;6:242-248	2004
Hall JE, Crook ED, Jones DW, Wofford MR, Dubbert PM Mechanisms of Obesity-Associated Cardiovascular and Renal Disease Am J Med Sci 2002 Sep;324(3):127-37	2002
Andrew ME, Jones DW, Schreiner PJ, Wofford MR, Wyatt SB, Brown CA, Young DB, Taylor HA Ethnicity and Unprovoked Hypokalemia in the Atherosclerosis Risk in Communities Study Am J Hypertens 2002;15:594-599	2002
Bakris G, Gradman A, Reif M, Wofford M, Munger M, Harris S, Vendetti J, Michelson E, Wang R Antihypertensive Efficacy of Candesartan in Comparison to Losartan: The Claim Study J Clin Hypertens. 2001;3:16-21	2001
Wong TY, Klein R, Couper D, Cooper L, Shahar E, Hubbard L, Wofford MR, Sharrett AR Retinal Microvascular Abnormalities and Incident Strokes: The Atherosclerosis Risk in Communities Study Lancet 2001;358:1134-40	2001
King DS, Jones DW, Wofford MR, Harkins KG, Harrell TK, Kelly KW Cognitive Impairment Associated with Atorvastatin Pharmacotherapy 2001;21(3):36	2001
King DS, Noble SL, Harrell TK, Wofford MR Education, Service, and Pharmaceutical Care Opportunities for Pharmacy Students Through Medical Missions Pharmacotherapy 2001;21(3):107	2001
Wofford MR, Anderson DC, Brown CA, Jones DW, Miller ME, Hall JE Antihypertensive Effect of - and - Adrenergic Blockade in Obese and Lean Hypertensive Subjects Am J Hypertens 2001;14:694-698	2001
Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL Antihypertensive Therapy and the Risk of Type 2 Diabetes Mellitus: The Atherosclerosis Risk in Communities (ARIC) Study N Engl J Med. 2000;342:905-12	2000
King DS, Wofford MR Obesity and Hypertension Drug Topics. 1999;144(1):59-68	1999
Wofford MR, Andrew ME, Pickett RA, Brown CA, Wyatt S, King D, Jones DW Obesity Hypertension in the Atheroslerosis Risk in Communities Cohort: Implications of Obesity Guidelines J Clin Hypertens. 1999;1:27-32	1999
Jones DW, Miller ME, Wofford MR, Anderson DC, Cameron ME, Willoughby DL, Adair CT, King NS The Effect of Weight Loss Intervention on Antihypertensive Medication Requirements in the Hypertension Optimal Treatment (HOT) Study Am J Hypertens. 1999;12:1175-1180	1999
Robbins MA, Stewart RN, Wofford MR Clinicopathologic Conference XXI. Case Records of the Department of Medicine University of Mississippi Medical Center. Journal of the Mississippi State Medical Association. 1998	1998
Riche DM,Fleming JW,Malinowski SS,Black CA, Miller KH, Wofford MR. Resistant nonalcoholic fatty liver disease amelioration with rosuvastatin and pioglitazone combination therapy in a patient with metabolic syndrome. Ann Pharmacother. 2014 Jan; 48 (1):137-41.
Review Article
Sucher BJ, King DS, Wofford MR Practical Management of Obesity Drug Topics 2002;146:9: 82-91	2002
King DS, Wofford MR, Stewart JL The renin-angiotensin system: A primary target for cardiovascular disease prevention Drug Topics 2002 Nov. 146(21):64-73	2002
Wofford MR, King DS, Wyatt SB, Jones DW Secondary Hypertension: Detection and Management for the Primary Care Provider J Clin Hypertens. 2000;2:124-131	2000
King DS, Wofford MR Identification/Management of Obstructive Sleep Apnea Drug Topics. 2000;144(15):41-50	2000
King DS, Wofford MR Obesity and Diabetes Mellitus Drug Topics. 1999;144(2):69-78	1999
Abstracts
Minor D, Butler K, Wofford M Blood pressure control rates among patients with chronic kidney disease or diabetes in a hypertension referral clinic Proceedings of the ASHP 2010 Summer Meeting and Exhibition: An Intensive Educational and Skills-Building Experience for Health-System Pharmacy Leaders, Tampa, FL. June 7, 2010:43	2010
Long RC, King DS, Wofford MR, Harkins KG, Stewart JL Hepatocellular Necrosis Associated with Labetalol Am J Hypertens 2005 May 18(5 Pt 2):67A	2005
Wofford MR, KIng DS, Harkins KG, Stewart JL, Noble SL, Usery JB, Shimozono T Incidence of Hyperkalemia Associated with Aldosterone Antagonists in a Hypetension Referral Center Am J Hypertens 2005 May 18(5Pt 2):76A	2005
Rice SD, King DS, Harrell TK, Stewart JL, Wofford MR Hypertension Awareness, Control and Treatment in Rural Mississippi: Morton Have-A-Heart Project Am J Hypertens 2005 May 18(5 Pt 2):149A	2005
Stewart JL, Harkins K, King D, Wofford M The Effects of Extended Duty Hours on Ambulatory Blood Pressures in Internal Medicine, Pediatric, and Med-Peds Residents Am J Hypertens 2004 May 17 (5 Pt 2):57A	2004
King DS, Barud SJ, Wofford MR, Noble SL, Fontenot TM, Reed RR, Harkins KG, Stewart JL, Wyatt SB, McDaniel A Improving Medication Adherence in a Southeastern Hypertension Clinic Using Adhererx Am J Hypertens 2004 May 17(5 Pt 2):222A	2004
Reed RR, King DS, Wofford MR, Adair CM, Harkins KG, Stewart JL, Wyatt SB, Harrell TK Variations in Blood Pressure Control Throughout the Dosing Interval with Morning Versus Evening Dosing of Once-Daily Antihypertensive Medications Am J Hypertens 2004 May 17(5 Pt 2):121A	2004
Barud SJ, King DS, Reed RR, Harkins KG, Wofford MR, Noble SL Screening for Depression and Anxiety in a Hypertension Specialty Clinic Am J Hypertens 2004 May 17(5 Pt 2):224A	2004
Stewart JL, King DS, Harrell TK, Davy BM, Wofford MR, Noble SL Increasing awareness, detection, and management of cardiovascular risk factors in children and adolescents Am J Hypertens 2003 May;16(5 Pt 2):249A	2003
King DS, Thomas JR, Habeeb GE, Harkins KG, Harrell TK, Noble SL, Stewart JL, Wofford MR, Wyatt SB, Smith M, Owens B Medication adherence in a southeastern hypertension clinic Am J Hypertens 2003 May;16(5 Pt 2):234A	2003
King DS, Stewart JL, Cloy JA, Noble SL, Wofford MR, Samuel J, Aiello M, Tonore TB Addressing pediatric hypertension in residency training programs Am J Hypertens 2003 May;16(5 Pt 2):237A	2003
Habeeb GE, Wofford MR, King DS, Wood RL, Noble SL A rare case of labetalol induced hepatic necrosis Am J Hypertens 2003 May;16(5 Pt 2):117A-118A	2003
Thomas JR, King DS, Wofford MR, Habeeb, GE, Harkins KG, Stewart JL, Wyatt SB, Noble SL Strategies for increasing influenza vaccination rates among a high-risk cardiovascular population Am J Hypertens 2003 May;16(5 Pt 2):235A	2003
Wofford MR, Davis MM, Harkins KG, King DS, Warnock JL, Wyatt SB, Jones DW Screening for Primary Aldosteronism in Hypertensive Patients Am J Hypertension 2000;13(4)Part 2: 8A-9A	2003
Wofford MR, King DS, Habeeb GE, Harkins KG, Stewart JL, Wyatt SB Long-term management of hypertensive patients with primary aldosteronism Am J Hypertens 2003 May;16(5 Pt 2):256A	2003
Harrell TK, Horton NN, King DS, Wofford MR Assessment of cardiovascular risk factor awareness and accentuation of early detection among African-American college students Am J Hypertens 2003 May;16(5 Pt 2):244A-245A	2003
Harkins KG, King DS, Habeeb GE, Stewart JL, Wyatt SB, Wofford MR Use of a long-acting loop diuretic to improve blood pressure control Am J Hypertens 2003 May;16(5 Pt 2):118A	2003
Wofford MR, Harkins KG, King DS, Habeeb GE, Wyatt SB, Jones DW Accurate Cuff Size in Blood Pressure Measurement American Journal of Hypertension 2002:15(4) Part 2;92A	2002
King DS, Noble SL, Wyatt SB, Wofford MR, Harrell TK, Walker ER A Statewide Campaign for Increasing Health Awareness: Know Your Numbers American Journal of Hypertension 2002:15(4) Part 2;224A	2002
King DS, Wofford MR, Harrell TK, Noble SL Blood pressure measurement: selection of appropriate cuff size for office and home monitoring Pharmacotherapy 2002:22(10)1333	2002
Wyatt SB, Harkins KG, King DS, Wofford MR, Jones DW Invoking Source of Spiritual Sustenance as a Treatment Strategy in African Americans with Hypertension American Journal of Hypertension 2002:15(4) Part 2;145A	2002
King DS, Wofford MR, Wyatt SB, Habeeb GE, Harkins KG, Harrell TK, Jones DW, Sucher B, Noble SL Assessing Health Awareness in Patients with Hypertension American Journal of Hypertension 2002:15(4) Part 2;223-224A	2002
Harrell TK, King DS, Crenshaw HT, Wofford MR, Jones DW Incorporation of a cardiovascular risk factor awareness program in the core curriculum of a rural Mississippi high school Pharmacotherapy 2002:22(10)1375	2002
Harrell TK, Wofford MR, Wyatt SB, Jones DW The Morton Have-A-Heart Project: Evaluation of Elevated Blood Pressures, Total Cholesterol Levels, and Glucose Levels in a Rural Mississippi Community American Journal of Hypertension 2002:15(4) Part 2;224A	2002
King DS, Wofford MR, Harrell TK, Noble SL Utilizing a self-administered health awareness questionnaire to increase clinic educational efforts Pharmacotherapy 2002:22(10)1336	2002
Egan B, Wofford M, Calhoun D, Nesbitt S, Cohn J, Julius S Leptin is Associated with Insulin Resistance and Impaired Small Artery Distensibility in Subjects with High Normal Blood Pressure American Journal of Hypertension 2002:15(4) Part 2;221-222A	2002
Horton NN, Harrell TK, King DS, Wofford MR, Low AK, Noble SL Assessment of Awareness of Obesity and Blood Pressure as Cardiovascular Risk Factors in African-American College Students Obesity Research 2001:9(3)163S	2001
Walters LA, Hallam J,Wofford MR, King DS, Loyd S A Tale of Two Cardiovascular Health Planning Groups Preventive Medicine 2001:33(2)S18	2001
King DS, Jones DW, Wofford MR, Wyatt SB, Tidwell BH, Harkins KG, Harrell TK Pilot Project for Reduction of Cardiovascular Disease in Mississippi Rural Communities Am J Hypertension 2001;14(4)Part 2:247A	2001
Wofford MR, King DS, Wyatt SB, Harkins KG, Kelly KW, Jones DW Screening for Obstructive Sleep Apnea (OSA) in Patients with Hypertension Am J Hypertension 2001;14(4)Part 2:255A	2001
Harrell TK, King DS, Wofford MR, Wyatt SB, Jones DW Selection of a Rural Community Site for a Comprehensive Enabling Cardiovascular Disease Risk Reduction Intervention Preventive Medicine 2001:33(2)S14	2001
King DS, Kelley KW, Wyatt SB, Wofford MR, Harkins KG, Jones DW Utility of Ambulatory Blood Pressure Monitoring in a Hypertension Specialty Clinic Am J Hypertension 2001;14(4)Part 2:49A	2001
Harrell TK, Horton NN, King DS, Wofford MR, Low AK, Noble SL Assessment of the Awareness of Obesity and Blood Pressure as Cardiovascular Risk Factors in a Historically African-American University Pharmacotherapy 2001:21(10)1262	2001
Wofford MR, Harkins KG, King DS, Wyatt SB, Jones DW Screening for Primary Aldosterone in Older Patients with Hypertension Am J Hypertension 2001;14(4)Part 2:253A	2001
Wofford MR, Harrell TK, King DS, Stewart JL The Morton Have-A-Heart Adolescent Obesity Project: A School-Based Program to Heighten Awareness Among Medicine-Pediatric Residents Preventive Medicine 2001;33(2):35	2001
Harkins KG, King DS, Wofford MR, Wyatt SB, Jones DW Iatrogenic Hypotension Associated with Normal-Tension Glaucoma Am J Hypertension 2001;14(4)Part 2:46A	2001
Wyatt SB, Harkins KG, King DS, Wofford MR, Jones DW Prevalence of Secondary Hypertension in a Southeastern US Hypertension Referral Center Am J Hypertension 2001;14(4)Part 2:253A	2001
Kelley KW, King DS, Wofford MR, Wyatt SB, Jones DW The Use of Ambulatory Blood Pressure Monitoring to Influence Drug Regimens in a Hypertension Specialty Clinic Pharmacotherapy 2001:21(10)1261-2	2001
Brown A, Andrew M, Clemons T, King D, Taylor H, Wofford M, Wyatt S, Jones D Classification of JNC VI Blood Pressure Stages and Risk Groups in the ARIC Study Am J Hypertension 2000;13(4)Part 2:270A	2000
King DS, Noble SL, Harkins KG, Wofford MR, Harrell TK, Ramsey LA, Replogle WH, Tidwell BH Evaluation of Compliance with National Cholesterol Education Program Recommendations for Screening and Treatment of Hyperlipidemia in Medical Resident Primary Care Training Clinics Pharmacotherapy 2000;20(10):1235	2000
Harkins KG, King DS, Wofford MR, Brown CA, Wyatt SB, Miller-Davis ME, Ramsey LA, Jones DW Screening for Dyslipidemia in Resident Training Clinics: Is Cardiovascular Risk Management Adequate Am J Hypertension 2000;13(4)Part 2:101A	2000
Wofford MR, Andrew ME, King DS, Stevens J, Wyatt SB, Jones DW Implications of Obesity Guidelines to the Atherosclerosis Risk in Communities Cohort Ethnicity & Disease. 2000;10(2):292-293	2000
Harrell TK, Horton NN, King DS, Wofford MR, Low AK, Noble SL Women=s Health Initiative of Mississippi: An Innovative Approach to Promoting Wellness Obesity Research 2000;8(1):104S	2000
King DS, Wyatt SB, King NS, Wofford MR, Statham LH, Pearson MM, Harrell TK, Jones DW Improvement in Blood Pressure Control Through Interdisciplinary Medication Assistance Efforts in Hypertensive Patients with Multiple Metabolic Syndrome Am J Hypertension 2000;13(4)Part 2:18A	2000
Wofford MR, Davis MM, Harkins KG, King DS, Warnock JL, Wyatt SB, Jones DW Screening for Primary Aldosteronism in Hypertensive Patients Am J Hypertension 2000;13(4)Part 2: 8A-9A	2000
King DS, Wyatt SB, Wofford MR, Harrell TK, Jones DW Improvement in Blood Pressure Control Through Interdisciplinary Medication Assistance Efforts in Hypertensive Patients with Multiple Metabolic Syndrome Pharmacotherapy 2000;20(10):1235	2000
Wofford MR, Adair C, Anderson DC, Hall JE, Miller ME, Jones DW Alpha and Beta Blockade in Obese and Lean Hypertensive Subjects Hypertension. 1998;32(3);595	1998
Wofford MR, Miller ME, Cameron ME, Willoughby DL, Adair CM, Jones DW Effects of Weight Loss Intervention in HOT Weight Loss Substudy Participants Am J Hypertension. 1997;10(4)Part 2:84A	1997
Jones DW, Miller ME, Wofford MR, Anderson DC, Cameron ME, Willoughby DL, Adair CM, King NS The Effect of Weight Loss Intervention on Antihypertensive Medication Requirements in the Hypertension Optimal Treatment (HOT) Study Hypertension. 1997;30(3):486	1997
Book Chapter
Recekelhoff J, Wofford MR Hypertension In Women Women & Health, Second Edition. Goldman MB, Troisi R, Rexrode KM (ed): Elsovier Inc., 2013,pp 1069-1079.	2013
Riche, D.M.,Wilson, L.,Terry Jackson R.,Wofford, M.R.,Adams C. Effect on Institutional Revenue of Clinical Pharmacy Services in an Ambulatory Care Clinic Americal Journal of Health-System Pharmacy	2013
Riche, D.M., McEwen, C.L.,Riche, K.D.,Sherman, J.J.,Wofford, M.R., Deschamp, D., Griswold, M. Analysis of Safety from a Human Clinical Trial with Pterostilbene Journal of Toxicology	2013
Stewart JL,Wofford MR Metabolic Syndrome Pharmacotherapy in Primary Care , McGray-Hill;New York City,pp 293-297	2008
Wofford MR, Hall JE Pathophysiology and Treatment of Obesity Hypertension Current Pharmaceutical Design. 2004;10:3621-3637	2004
Jones DW, Wofford MR Intervention in Minorities Whelton PK, HE J, Louis GT (ed): Lifestyle Modification for the Prevention and Treatment of Hypertension: New York, Marcel Dekker, Inc., 2003, pp365-378	2003
Wofford MR Primary Aldosteronism In Egan BM, Basile JN, Lackland DT: Hypertension Hot Topics: Philadelphia, Hanley & Belfus, Inc., 2003, pp 99-104	2003
Wofford MR, Jones DW Pheochromocytoma: Detection and Management In: Hypertension:A Companion to Brenner and Rector’s The Kidney. Oparil, S, Weber, M, eds. Philadelphia: Elsevier Saunders, pp. 807-812
Book
Linn WD, Wofford MR, O'Keefe ME, Posey ML Pharmacotherapy in Primary Care McGraw-Hill;New York City, 2008	2008
Jones DW, King DS, Wofford MR Hypertension Pearls Philadelphia, Hanley & Belfus, Inc. 2004	2004

Presentations

Invited Symposia, Approach to the Patient with Resistant Hypertension, Cardiovascular Disease Symposium, Jackson, MS	04/2013
Regional Invited Seminars/Lectures, Cardiovascular Health, Advanced Practice Providers, Jackson, MS	03/2013
State/Local Invited Seminars/Lectures, Update in Resistant Hypertension, Advanced Practice Provider Conference, Jackson, MS	02/2013
Invited Symposia, Update in Resistant Hypertension, Southern Society of General Internal Medicine, New Orleans, Louisiana	02/2013
Regional Invited Seminars/Lectures, Updates in Hypertension Management., Southern SGIM 2013 Regional Meeting, New Orleans, LA	02/2013
Clinical Hypertension Review Course, American Society of Hypertension, Jackson, MS	04/2012
Faculty Lectures on Renal Mechanism, Jackson, MS	04/2012
Hypertension in Children and Adolescents, Faculty Lecture, Jackson, MS	04/2012
Hypertension In Elderly, Faculty Lecture, Jackson, MS	04/2012
Hypertension in Pregnancy, Faculty Lecture, Jackson, MS	04/2012
Hypertensive Renal Disease, Jackson, Ms	04/2012
Office and Out-of-Office Blood Pressure Measurement, Jackson, MS	04/2012
Regional Invited Seminars/Lectures, Hypertension Treatment in Primary Care: Primary Care Symposium, Consortium for Southeastern Hypertension Control, Jackson, MS	10/2010
Poster Presentation, Assessment of 24-Hour Blood Pressure Effects: Metoprolol versus Nebivolol, American Society of Health-System Pharmacists Midyear Meeting, Orlando, Florida	12/2008
Poster Presentation, Prevalence of Resistant Hypertension in a Hypertension Clinic at a Large Academic Medical Center, American Society of Health-System Pharmacists Midyear Meeting, Orlando, Florida	12/2008
Poster Presentation, Evaluation of Hyperkalemia and the Use of Aldosterone Antagonists in Resistant and Secondary Hypertension in a Hypertension Referral Center and Family Medicine Practice, American Society of Health-System Pharmacists Midyear Meeting, Orlando, Florida	12/2008
Poster Presentation, Metabolic and Cardiac Changes in Obese Hypertensive Patients Using Eplerenone, American Society of Health-System Pharmacists Midyear Meeting, Orlando, Florida	12/2008
Regional Invited Seminars/Lectures, Treatment of Hypertension in Pregnancy. Hypertension in Obesity, Southern Medical Association 9th Annual Conference on Hypertension Improving Outcomes: A Case-Oriented Approach, New Orleans, LA	06/2005
Poster Presentation, Incidence of Hyperkalemia Associated with Aldosterone Antagonists in a Hypertension Referral Center, American Society of Hypertension 20th Annual Scientific Meeting, San Francisco, CA	05/2005
Regional Invited Seminars/Lectures, Treatment of Hypertension in Pregnancy, American Society of Hypertension Gulf Coast Regional Chapter, New Orleans, LA	2005
State/Local Invited Seminars/Lectures, Hypertension in Pediatrics and Adolescents, Mississippi Association of Public Health Physicians, Jackson, MS	12/2004
State/Local Invited Seminars/Lectures, Metabolic Syndrome: An Ounce of Prevention is Worth a Pound of Cure, Mississippi Society of Hospital Pharmacists, Philadelphia, MS	07/2004
State/Local Invited Seminars/Lectures, Hypertension in Adolescents, American Academy of Pediatrics Mississippi Chapter, Jackson, MS	05/2004
Poster Presentation, Improving Medication Adherence in a Southeastern Hypertension Clinic Using Adhererx., American Society of Hypertension 19th Annual Scientific Meeting, New York, NY	05/2004
State/Local Invited Seminars/Lectures, Isolated Systolic Hypertension, Information Quality Healthcare, Jackson, MS	05/2004
Poster Presentation, Screening for Depression and Anxiety in a Hypertension Specialty Clinic, American Society of Hypertension 19th Annual Scientific Meeting, New York, NY	05/2004
Poster Presentation, The Effects of Extended Duty Hours on Ambulatory Blood Pressures in Internal Medicine, Pediatric, and Med-Peds Residents, American Society of Hypertension 19th Annual Scientific Meeting, New York, NY	05/2004
Poster Presentation, Variations in Blood Pressure Control Throughout the Dosing Interval with Morning Versus Evening Dosing of Once-Daily Antihypertensive Medications, American Society of Hypertension 19th Annual Scientific Meeting, New York, NY	05/2004
State/Local Invited Seminars/Lectures, Hypertension in Adolescents, Mississippi State Department of Health, Primary Care Symposium, Jackson, MS	02/2004
Regional Invited Seminars/Lectures, Hypertension and Hyperlipidemia: Are We Treating the Same Disease?, American Society of Hypertension Gulf Coast Regional Chapter, New Orleans, LA	2004
State/Local Invited Seminars/Lectures, Hypertension: Management and Prevention, Mississippi Association of Public Health Physicians, Jackson, Mississippi	12/2003
Poster Presentation, A rare case of labetalol induced hepatic necrosis, American Society of Hypertension 18th Annual Scientific Meeting, New York, NY	05/2003
Poster Presentation, Addressing pediatric hypertension in residency training programs, American Society of Hypertension 18th Annual Scientific Meeting, New York, NY	05/2003
Poster Presentation, Assessment of cardiovascular risk factor awareness and accentuation of early detection among African-American college students, American Society of Hypertension 18th Annual Scientific Meeting, New York, NY	05/2003
Poster Presentation, Increasing awareness, detection, and management of cardiovascular risk factors in children and adolescents, American Society of Hypertension 18th Annual Scientific Meeting, New York, NY	05/2003
Poster Presentation, Long-term management of hypertensive patients with primary aldosteronism, American Society of Hypertension 18th Annual Scientific Meeting, New York, NY	05/2003
Poster Presentation, Medication adherence in a southeastern hypertension clin, American Society of Hypertension 18th Annual Scientific Meeting, New York, NY	05/2003
Poster Presentation, Strategies for increasing influenza vaccination rates among a high-risk cardiovascular population, American Society of Hypertension 18th Annual Scientific Meeting, New York, NY	05/2003
Poster Presentation, Use of a long-acting loop diuretic to improve blood pressure control, American Society of Hypertension 18th Annual Scientific Meeting	05/2003
State/Local Invited Seminars/Lectures, Hypertension Update, University of Mississippi Dental School - Dean’s Professional Development Lecture Series, Jackson, MS	04/2003
State/Local Invited Seminars/Lectures, ALLHAT: Implications to Clinical Care, University of Mississippi Medical Center, Jackson, MS	04/2003
State/Local Invited Seminars/Lectures, Hypertension Treatment: Attention to Targets, University of Mississippi Medical Center, Department of Medicine’s First Gathering of Alumni and Friends, Jackson, MS	03/2003
Poster Presentation, Incorporation of a cardiovascular risk factor awareness program in the core curriculum of a rural Mississippi high school, American College of Clinical Pharmacy 2002 Annual Meeting, Albuquerque, NM	10/2002
Poster Presentation, Utilizing a self-administered health awareness questionnaire to increase clinic educational efforts, American College of Clinical Pharmacy 2002 Annual Meeting, Albuquerque, NM	10/2002
Poster Presentation, Blood pressure measurement: selection of appropriate cuff size for office and home monitoring, American College of Clinical Pharmacy 2002 Annual Meeting, Albuquerque, NM	09/2002
State/Local Invited Seminars/Lectures, The Renin-Angiotensin System: A Primary Target for Cardiovascular Disease Prevention, University of Mississippi Department of Medicine Grand Rounds, Jackson, MS	09/2002
State/Local Invited Seminars/Lectures, Ensuring Optimal Therapy in the Primary Care Setting - Hypertension Management, Diabetes Update, Lipids 2002, Mississippi Academy of Family Practice Annual Meeting, Destin, FL	07/2002
Poster Presentation, A Statewide Campaign for Increasing Health Awareness: Know Your Numbers, American Society of Hypertension 17th Annual Scientific Meeting, New York, NY	05/2002
Poster Presentation, Accurate Cuff Size in Blood Pressure Measurement, American Society of Hypertension 17th Annual Scientific Meeting, New York, NY	05/2002
Poster Presentation, Assessing Health Awareness in Patients with Hypertension, American Society of Hypertension 17th Annual Scientific Meeting, New York, NY	05/2002
Poster Presentation, Invoking Source of Spiritual Sustenance as a Treatment Strategy in African Americans with Hypertension, American Society of Hypertension 17th Annual Scientific Meeting, New York, NY	05/2002
The Morton Have-A-Heart Project: Evaluation of Elevated Blood Pressures, Total Cholesterol Levels, and Glucose Levels in a Rural Mississippi Community, American Society of Hypertension 17th Annual Scientific Meeting, New York, NY	05/2002
State/Local Invited Seminars/Lectures, Hypertension Emergencies: Assessment and Management, Mississippi Access for Rural Care=s Clinical Conference, Hattiesburg, MS	02/2002
State/Local Invited Seminars/Lectures, Hypertension in the Elderly: Foscus on Systolic Blood Pressure, Greenwood Leflore Hospital, Greenwood, MS	02/2002
National and International Invited Seminars/Lectures, Obesity and It’s Effects in Comorbid Conditions, American Society of Health-Systems Pharmacists Midyear Clinical Meeting in New Orleans, New Orleans, LA	12/2001
State/Local Invited Seminars/Lectures, Hypertension in the Elderly, American Society of Hypertension Gulf Central Chapter, New Orleans, LA	11/2001
Poster Presentation, The Morton Have-A-Heart Adolescent Obesity Project: A School-Based Program to Heighten Awareness Among Medicine-Pediatric Residents, First National CDC Prevention Conference on Heart Disease and Stroke, Atlanta, GA	08/2001
Poster Presentation, Screening for Primary Aldosterone in Older Patients with Hypertension, 16th Scientific Meeting of the American Society of Hypertension, San Francisco, CA	05/2001
State/Local Invited Seminars/Lectures, Hypertension in the Elderly, Delta Medical Society, Greenwood Leflore Hospital, Greenwood, MS	04/2001
State/Local Invited Seminars/Lectures, Clinicopathologic Conference (CPC) - Medicine Resident Noon Conference, The University of Mississippi Medical Center, Jackson, MS	11/2000
State/Local Invited Seminars/Lectures, A Focus on Systolic Hypertension in the Elderly, University of Mississippi Medical Center Grand Rounds, Jackson, MS	11/2000
National and International Invited Seminars/Lectures, Why Focus on Systolic Blood Pressure, National Scientific Sessions of Consortium for Southeastern Hypertension Control, Savannah, Georgia	11/2000
Poster Presentation, Improvement in Blood Pressure Control through Interdisciplinary Medication Assistance Efforts in Hypertensive Patients with Multiple Metabolic Syndrome, Mississippi Nurse=s Association Annual Convention, Biloxi, MS	10/2000
Poster Presentation, Women=s Health Initiative of Mississippi: An Innovative Approach to Promoting Wellness, North American Association for the Study of Obesity, Annual Meeting, Long Beach, CA	10/2000
State/Local Invited Seminars/Lectures, Mental Health Issues of Women, Mississippi Department of Mental Health First Annual Conference on Alzheimer’s Disease and Psychiatric Disorders in the Elderly, Biloxi, MS	08/2000
National and International Invited Seminars/Lectures, Implications of Obesity Guidelines to the Atherosclerosis Risk in Communities Cohort, The International Society on Hypertension in Blacks, Las Croabas, Puerto Rico	06/2000
Poster Presentation, Evaluation of Compliance with National Cholesterol Education Program Recommendations for Screening and Treatment of Hyperlipidemia in Medical Resident Primary Care Training Clinics, 15th Scientific Meeting of the American Society of Hypertension, New York, NY	05/2000
National and International Invited Seminars/Lectures, Screening for Primary Aldosteronism in Hypertension Patients, The American Society of Hypertension, New York, New York	05/2000
State/Local Invited Seminars/Lectures, State Department of Health’s First Disparities Conference, Jackson Medical Mall, Jackon, MS	03/2000
National and International Invited Seminars/Lectures, Alpha and Beta Blockade in Obese versus Lean Hypertensives, American Heart Association 52nd Annual Fall Conference, Philadelphia, PA	09/1998
State/Local Invited Seminars/Lectures, Department of Medicines Division Directors Retreat, Mentoring in an Academic medicine Setting: Ideas for Improvement at All Levels, Philadelphia, MS	04/1998
State/Local Invited Seminars/Lectures, Mississippi Hypertension Disease Management Network, Cleveland, MS	03/1998
State/Local Invited Seminars/Lectures, Department of Medicines Resident Retreat, Annual Resident Orientation, Jackson, MS	1998
Regional Invited Seminars/Lectures, Hypertension in the Southeast, The Mississippi Cooperative Hypertension Evaluation and Treatment Network, Delta Regional Medical Center, Continuing Medical Education	06/1997
State/Local Invited Seminars/Lectures, Computers in Medicine: the Implementation of SMS, Grand Rounds, University of Mississippi, Department of Medicine, Jackson, MS	06/1997
Poster Presentation, Effects of Weight Loss Intervention in HOT Weight Loss Substudy Participants, American Society of Hypertension, San Francisco, CA	05/1997

Teaching Experience

621, Medicine, Course, Preceptor, Introduction to Clinical Medicine	Spring 2013
621, Medicine, Course, Preceptor, Introduction to Clinical Medicine	Fall 2012
621, Medicine, Small Group, Guest Presenter, Introduction to Clinical Medicine	Spring 2012
621, Medicine, Course, Preceptor, Introduction to Clinical Medicine	Spring 2012
621, Medicine, Course, Preceptor, Introduction to Clinical Medicine	Fall 2011
621, Medicine, Small Group, Guest Presenter, Introduction to Clinical Medicine	Fall 2011
Lecture, Lecturer, Mandatory Resident Conference	Spring 2011
Lecture, Lecturer, Consortium for Southeastern Hypertension Control	Summer 2010

Directed Student Learning

Mentor, Advised: Julie Raviero

2011 - 2011

Wofford, Marion R., M.D.

Education

Current Positions

Education

Specialty Certification Licensure

Academic Appointments or Other Previous Appointments

Honors, Awards, and Recognition

Professional Membership and Service

Committee Service

Other Service

Sponsored Program Funding

Publications

Article

Journal Article

Review Article

Abstracts

Book Chapter

Book

Presentations

Teaching Experience

Directed Student Learning

Services & Procedures